BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 34919263)

  • 21. Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History.
    Sud A; Thomsen H; Sundquist K; Houlston RS; Hemminki K
    J Clin Oncol; 2017 May; 35(14):1584-1590. PubMed ID: 28384078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcome of breast cancer occurring after treatment for Hodgkin's lymphoma: case-control analysis.
    Alm El-Din MA; Hughes KS; Raad RA; Goldberg SI; Aisenberg AC; Niemierko A; Taghian AG
    Radiat Oncol; 2009 Jun; 4():19. PubMed ID: 19566943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of breast cancer and breast cancer characteristics in women treated with supradiaphragmatic radiation for Hodgkin lymphoma: Mayo Clinic experience.
    Wahner-Roedler DL; Nelson DF; Croghan IT; Achenbach SJ; Crowson CS; Hartmann LC; O'Fallon WM
    Mayo Clin Proc; 2003 Jun; 78(6):708-15. PubMed ID: 12934780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma-Identification of high-risk populations to guide surveillance: A report from the Late Effects Study Group.
    Holmqvist AS; Chen Y; Berano Teh J; Sun C; Birch JM; van den Bos C; Diller LR; Dilley K; Ginsberg J; Martin LT; Nagarajan R; Nathan PC; Neglia JP; Terenziani M; Tishler D; Meadows AT; Robison LL; Oberlin O; Bhatia S
    Cancer; 2019 Apr; 125(8):1373-1383. PubMed ID: 30556153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast Imaging in Women Previously Irradiated for Hodgkin Lymphoma.
    Horst KC; Fero KE; Hancock SL; Advani RH; Ikeda DM; Daniel B; Rosenberg SA; Donaldson SS; Hoppe RT
    Am J Clin Oncol; 2016 Apr; 39(2):114-9. PubMed ID: 24390271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage.
    Howell SJ; Searle C; Goode V; Gardener T; Linton K; Cowan RA; Harris MA; Hopwood P; Swindell R; Norman A; Kennedy J; Howell A; Wardley AM; Radford JA
    Br J Cancer; 2009 Aug; 101(4):582-8. PubMed ID: 19672261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of second malignancies in patients with early-stage classical Hodgkin's lymphoma treated in a modern era.
    LeMieux MH; Solanki AA; Mahmood U; Chmura SJ; Koshy M
    Cancer Med; 2015 Apr; 4(4):513-8. PubMed ID: 25620577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Best practice & research clinical haematology: Screening for breast cancer in hodgkin lymphoma survivors.
    Wong SM
    Best Pract Res Clin Haematol; 2023 Dec; 36(4):101525. PubMed ID: 38092481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients.
    Yahalom J; Petrek JA; Biddinger PW; Kessler S; Dershaw DD; McCormick B; Osborne MP; Kinne DA; Rosen PP
    J Clin Oncol; 1992 Nov; 10(11):1674-81. PubMed ID: 1403050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma.
    Opstal-van Winden AWJ; de Haan HG; Hauptmann M; Schmidt MK; Broeks A; Russell NS; Janus CPM; Krol ADG; van der Baan FH; De Bruin ML; van Eggermond AM; Dennis J; Anton-Culver H; Haiman CA; Sawyer EJ; Cox A; Devilee P; Hooning MJ; Peto J; Couch FJ; Pharoah P; Orr N; Easton DF; Aleman BMP; Strong LC; Bhatia S; Cooke R; Robison LL; Swerdlow AJ; van Leeuwen FE
    Blood; 2019 Mar; 133(10):1130-1139. PubMed ID: 30573632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of subsequent primary lymphoma in a cohort of 69,460 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study.
    Dudley IM; Sunguc C; Heymer EJ; Winter DL; Teepen JC; Belle FN; Bárdi E; Bagnasco F; Gudmundsdottir T; Skinner R; Michel G; Byrne J; Øfstaas H; Jankovic M; Mazić MČ; Mader L; Loonen J; Garwicz S; Wiebe T; Alessi D; Allodji RS; Haddy N; Grabow D; Kaatsch P; Kaiser M; Maule MM; Jakab Z; Gunnes MW; Terenziani M; Zaletel LZ; Kuehni CE; Haupt R; de Vathaire F; Kremer LC; Lähteenmäki PM; Winther JF; Hjorth L; Hawkins MM; Reulen RC
    Cancer; 2023 Feb; 129(3):426-440. PubMed ID: 36444554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of male breast cancer after Hodgkin lymphoma.
    de Vries S; Krul IM; Schaapveld M; Janus CPM; Rademakers SE; Roesink JM; Nijziel MR; Bilgin YM; Aleman BMP; van Leeuwen FE
    Blood; 2023 Aug; 142(9):806-811. PubMed ID: 37390297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphoma.
    Chowdhry AK; McHugh C; Fung C; Dhakal S; Constine LS; Milano MT
    Cancer; 2015 May; 121(9):1436-45. PubMed ID: 25572913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Radiation and Procarbazine Dose With Risk of Colorectal Cancer Among Survivors of Hodgkin Lymphoma.
    Geurts YM; Shakir R; Ntentas G; Roberti S; Aznar MC; John KM; Ramroth J; Janus CPM; Krol ADG; Roesink JM; van der Maazen RWM; Zijlstra JM; Darby SC; Aleman BMP; van Leeuwen FE; Cutter DJ; Schaapveld M
    JAMA Oncol; 2023 Apr; 9(4):481-489. PubMed ID: 36729438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A population-based study of prognosis and survival in patients with second primary thyroid cancer after Hodgkin lymphoma.
    Chowdhry AK; Fung C; Chowdhry VK; Bergsma D; Dhakal S; Constine LS; Milano MT
    Leuk Lymphoma; 2018 May; 59(5):1180-1187. PubMed ID: 28862484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.
    Wong SM; King T; Boileau JF; Barry WT; Golshan M
    Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical Management and Contralateral Breast Cancer Risk in Women with History of Radiation Therapy for Hodgkin Lymphoma: Results from a Population-Based Cohort.
    Eisenberg ER; Weiss A; Prakash I; Skamene S; Basik M; Boileau JF; Ajjamada L; Pollak MN; Wong SM
    Ann Surg Oncol; 2022 Oct; 29(11):6673-6680. PubMed ID: 35668306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late mortality, secondary malignancy and hospitalisation in teenage and young adult survivors of Hodgkin lymphoma: report of the Childhood/Adolescent/Young Adult Cancer Survivors Research Program and the BC Cancer Agency Centre for Lymphoid Cancer.
    Bhuller KS; Zhang Y; Li D; Sehn LH; Goddard K; McBride ML; Rogers PC
    Br J Haematol; 2016 Mar; 172(5):757-68. PubMed ID: 26727959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast carcinoma in women previously treated for Hodgkin disease: mammographic evaluation.
    Dershaw DD; Yahalom J; Petrek JA
    Radiology; 1992 Aug; 184(2):421-3. PubMed ID: 1320281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of radiation-related salivary gland carcinomas among survivors of Hodgkin lymphoma: a population-based analysis.
    Boukheris H; Ron E; Dores GM; Stovall M; Smith SA; Curtis RE
    Cancer; 2008 Dec; 113(11):3153-9. PubMed ID: 18823043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.